BCG inoculation for new corona purpose "Not recommended, stable supply to infants" April 8 19:47
Studies have been conducted abroad to see if the BCG vaccine vaccinated by babies is associated with a novel coronavirus infection, but has not been scientifically proven yet. However, the expectation of the effect is that some people who want to vaccinate are starting to appear, so the Vaccine Society of Japan is calling for a calm response.
BCG is a regular vaccine for 0-year-olds in Japan as a vaccine to prevent tuberculosis, but in some countries, such as the United States and Italy, it is not provided uniformly.
Under these circumstances, researchers from overseas have pointed out that in areas where regular BCG vaccination is performed, the number of people infected with the new coronavirus and the number of deaths tend to be small. Clinical studies are underway to determine whether BCG is involved in preventing infection and severity.
However, according to the Japan Vaccine Society and others, in response to such a move, there are some people in Japan who are expecting the effect of BCG and wanting to get a vaccine.
For this reason, the society last week issued a statement stating that "the effectiveness of BCG against the new coronavirus has not yet been scientifically confirmed, and it is not recommended to inoculate with the expectation of such effects."
According to the statement, the reason that the number of deaths etc. is suppressed in Japan compared to overseas is `` it is thought to be largely due to the self-restraint behavior of each citizen and mindfulness '', and `` Stability of vaccines for infants We must avoid situations in which supply is affected. "
According to Mihai Netea, a professor at the University of Radboud, who is conducting clinical research in the Netherlands, "it is well worth investigating whether BCG is effective, but it is not yet known scientifically. There is no reason to vaccinate for the purpose of preventing coronavirus. "